Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.320
+0.020 (0.61%)
Oct 31, 2025, 12:18 PM EDT - Market open

Silexion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2013FY 2012
Period Ending
Oct '25 Dec '24 Dec '23 Dec '13 Dec '12
2342--
Market Cap Growth
-26.20%-92.33%---
Enterprise Value
5141--
Last Close Price
3.3030.151464.75--
PB Ratio
--0.8113.99--
Debt / Equity Ratio
-1.13-1.130.06--
Quick Ratio
0.340.342.093.6410.47
Current Ratio
0.640.642.273.8510.64
Return on Equity (ROE)
----116.66%-
Return on Assets (ROA)
-193.54%-193.54%--62.13%-
Return on Capital (ROIC)
-427.70%-427.70%--73.07%-
Earnings Yield
-888.23%-510.30%-11.77%--
FCF Yield
-454.73%-261.25%-10.81%--
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q